Clobazam and Migraine - a phase IV clinical study of FDA data

Summary:

Migraine is reported as a side effect among people who take Clobazam (clobazam), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Lamotrigine, and have Epilepsy.

The phase IV clinical study analyzes which people have Migraine when taking Clobazam. It is created by eHealthMe based on reports of 14,346 people who have side effects when taking Clobazam from the FDA, and is updated regularly.

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Migraine?

Migraine (headache) is found to be associated with 2,045 drugs and 2,349 conditions by eHealthMe. Check the latest studies of Migraine.

On Jul, 07, 2026

14,346 people reported to have side effects when taking Clobazam.
Among them, 32 people (0.22%) have Migraine.

Among these 32 people:

How long have people been on Clobazam when they have Migraine? *

What is the gender of people who have Migraine when taking Clobazam? *

female: 61.29 %
male: 38.71 %

What is the age of people who have Migraine when taking Clobazam? *

What are other drugs people take besides Clobazam? *

What are other side effects people have besides Migraine? *

Headache (pain in head): 21 people, 65.62%
Fatigue (feeling of tiredness): 14 people, 43.75%
Pain: 13 people, 40.62%
Memory Loss: 13 people, 40.62%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 13 people, 40.62%
Dizziness: 11 people, 34.38%
Drowsiness: 9 people, 28.12%
Back Pain: 9 people, 28.12%
Joint Pain: 9 people, 28.12%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 28.12%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 15.62%
Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 12.50%
Sleep Disorder: 4 people, 12.50%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 12.50%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 12.50%
Primary Immunodeficiency Syndrome: 4 people, 12.50%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 12.50%
Nausea (feeling of having an urge to vomit): 4 people, 12.50%
Headache (pain in head): 4 people, 12.50%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and have Migraine?

- Check whether Migraine is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clobazam:

Clobazam (14,399 reports)

Migraine treatments and more:

Migraine (234,063 reports)

Browse all side effects of Clobazam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Migraine:

Migraine (2,045 drugs)

Browse all the conditions that are associated with Migraine:

Migraine (2,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clobazam (the active ingredients of Clobazam) and Clobazam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.